01 September 2003
Superoxide dismutase in clinical course of juvenile idiopathic arthritis
Med Sci Monit 2003; 9(4): 48-51 :: ID: 428637
Abstract
Background: The use of antioxidants as drugs that may control the inflammatory process in rheumatoid arthritis recently has become a widely studied hint. One of the most important components of antioxidant barrier in humans is enzyme superoxide dismutase (SOD). The experimental treatments with SOD were proved to be efficace in animals. The aim of the present study was to estimate the activity of SOD in patients with rheumatoid disease of childhood —juvenile idiopathic arthritis and to analyse it in different clinical aspects of the disease including its activity, course and time of duration. Material/Methods: A group of 68 children with JIA, aged from 3 to 18 years, patients of Rheumatologic Hospital in Sopot was examined in years 1996-2000. Juvenile idiopathic arthritis was diagnosed according to EULAR classification (Durban 1997). The control group consisted of 29 healthy children aged from 3 to 18 years. Superoxide dismutase activity was determined in full, heparinised blood with the use of spectrofotometric method of Randox. The study was accepted by the Local Comitee of Ethics.Results: A statistically important grow in SOD activity was found in group of children with JIA (2299.9 ±1773.1 U/gHb) com-pared to healthy group (1203 ±395.6 U/gHb). In polyarthricular form of disease the activity of SOD was also importantly higher than in control group.
Conclusions: In course of JIA, differently than in rheumatoid arthritis of adults, superoxide dismutase activity seems to be stimulated, so the treatment with egzogenous SOD may not be effective.
Keywords: juvenile idiopathic arthritis
Editorial
01 January 2023 : Editorial
Editorial: Current Status of Two Adjuvanted Malaria Vaccines and the World Health Organization (WHO) Strategy to Eradicate Malaria by 2030DOI: 10.12659/MSM.939357
Med Sci Monit 2023; 29:e939357
SARS-CoV-2/COVID-19
26 January 2023 : Editorial
Editorial: The XBB.1.5 (‘Kraken’) Subvariant of Omicron SARS-CoV-2 and its Rapid Global SpreadMed Sci Monit In Press; DOI: 10.12659/MSM.939580
19 January 2023 : Clinical Research
Evaluation of Health-Related Quality of Life and Mental Health in 729 Medical Students in Indonesia During ...Med Sci Monit In Press; DOI: 10.12659/MSM.938892
19 January 2023 : Clinical Research
Determining the Impact of the COVID-19 Pandemic on Dental Care in the Serbian Adult Population: An Online Q...Med Sci Monit 2023; 29:e939238
27 December 2022 : Clinical Research
Effect of Physiotherapy to Correct Rounded Shoulder Posture in 30 Patients During the COVID-19 Pandemic in ...Med Sci Monit 2022; 28:e938926
In Press
27 Jan 2023 : Database Analysis
Association Between Neutrophil-Lymphocyte Ratio and All-Cause Mortality in Critically Ill Patients with Chr...Med Sci Monit In Press; DOI: 10.12659/MSM.938554
27 Jan 2023 : Clinical Research
Proposal for a Simple Equation for Limb Muscle Weight CalculationMed Sci Monit In Press; DOI: 10.12659/MSM.938606
26 Jan 2023 : Editorial
Editorial: The XBB.1.5 (‘Kraken’) Subvariant of Omicron SARS-CoV-2 and its Rapid Global SpreadMed Sci Monit In Press; DOI: 10.12659/MSM.939580
20 Jan 2023 : Clinical Research
A Study of 42 Partially Edentulous Patients with Single-Crown Restorations and Implants to Compare Bone Los...Med Sci Monit In Press; DOI: 10.12659/MSM.939225
Most Viewed Current Articles
13 Nov 2021 : Clinical Research
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952